secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0000950170-24-123356
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q3 revenue beats at $62.7M; CFO Booth to depart June 2025; $100M buyback authorized
--------------------------------------------------------------------------------

- Q3 revenue $62.7M, down 4% YoY; net loss $(187.8)M includes $228.2M goodwill impairment; adjusted EBITDA $20.6M (33% margin).
- CFO Richard Booth to leave effective June 1, 2025; granted 92,379 RSUs as retention incentive; search for successor underway.
- Board authorized $100M stock repurchase program expiring Dec 31, 2025; replaces prior $20M program; no repurchases yet.
- Entered voting agreement with Advent International to limit excess voting shares above 40.3% proportionally.
- Guidance: Q4 revenue $60-61M, adjusted EBITDA $16-17M; full-year revenue $250-251M, adjusted EBITDA $77.5-78.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000095017024123356/0000950170-24-123356-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000095017024123356/dh-20241101.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-123356

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer